Tarceva (erlotinib recalls

The FDA has published 1 recall involving Tarceva (erlotinib since 2014. The latest was reported on 15 Oct 2014. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 15 Oct 2014

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tarceva (erlotinib is recalled

Potency & Assay1100%

Companies

Astellas Pharma US1100%

By year

20141100%

All tarceva (erlotinib recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
15 Oct 2014Drug	CLASS II	Tarceva (erlotinib) Tablets, 150 mg recalled by Astellas Pharma US	Astellas Pharma US	Potency & Assay	Nationwide

Should you stop taking Tarceva (erlotinib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.